| Absorption | 
      | Blood-Brain Barrier | BBB+ | 0.9766 | 
      | Human Intestinal Absorption | HIA+ | 0.9907 | 
      | Caco-2 Permeability | Caco2+ | 0.7407 | 
      | P-glycoprotein Substrate | Non-substrate | 0.8420 | 
      | P-glycoprotein Inhibitor | Non-inhibitor | 0.9751 | 
                                                     | Non-inhibitor | 0.9839 | 
      | Renal Organic Cation Transporter | Non-inhibitor | 0.9158 | 
        
            | Distribution | 
        
      | Subcellular localization | Lysosome | 0.6352 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.7952 | 
      | CYP450 2D6 Substrate | Non-substrate | 0.8462 | 
      | CYP450 3A4 Substrate | Non-substrate | 0.7982 | 
      | CYP450 1A2 Inhibitor | Non-inhibitor | 0.9103 | 
      | CYP450 2C9 Inhibitor | Non-inhibitor | 0.9626 | 
        | CYP450 2D6 Inhibitor | Non-inhibitor | 0.9758 | 
      | CYP450 2C19 Inhibitor | Non-inhibitor | 0.9783 | 
      | CYP450 3A4 Inhibitor | Non-inhibitor | 0.9862 | 
      | CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9175 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9482 | 
                                                                    | Non-inhibitor | 0.9738 | 
      | AMES Toxicity | Non AMES toxic | 0.9732 | 
      | Carcinogens | Carcinogens  | 0.6995 | 
      | Fish Toxicity | Low FHMT | 0.6105 | 
      | Tetrahymena Pyriformis Toxicity | Low TPT | 0.7136 | 
      | Honey Bee Toxicity | High HBT | 0.8235 | 
      | Biodegradation | Ready biodegradable | 0.6385 | 
      | Acute Oral Toxicity | III | 0.7149 | 
      | Carcinogenicity (Three-class) | Non-required | 0.4942 |